Domov › Akutna mieločna levkemija › South Carolina

Klinične študije za Akutna mieločna levkemija v South Carolina

16 študij za Akutna mieločna levkemija išče udeležence na lokacijah v South Carolina.

Mesta v South Carolina

Uradno besedilo študije (angleško)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
in še 5

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
in še 12

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
in še 4

Vključevanje udeležencevFaza 2

Starost 18–59 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
in še 4

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
in še 5

Vključevanje udeležencevFaza 2

Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
in še 5

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

Vključevanje udeležencevFaza 3

6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

MUSC Health University Medical Center, Charleston

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Bon Secours St. Francis Cancer Center, Greenville

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

Vključevanje udeležencevFaza 1/2

Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Prisma Health Richland Hospital, Columbia

Vključevanje udeležencevFaza 3

29 Days – 21 Years · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Prisma Health, Greenville

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical University of South Carolina, Charleston

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Medical University of South Carolina, Charleston

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT02074839

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Hollings Cancer Center, Charleston

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 30. apr. 2026 · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Medical University of South Carolina, Charleston

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 24. mar. 2026 · NCT04988555

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.